Ted W. Love
Net Worth

Last updated:

What is Ted W. Love net worth?

The estimated net worth of Dr. Ted W. Love is at least $98,511,354 as of 27 Sep 2022. He owns shares worth $70,862,014 as insider, has earned $16,349,340 from insider trading and has received compensation worth at least $11,300,000 in Global Blood Therapeutics, Inc..

What is the salary of Ted W. Love?

Dr. Ted W. Love salary is $1,130,000 per year as Pres, Chief Executive Officer & Director in Global Blood Therapeutics, Inc..

How old is Ted W. Love?

Dr. Ted W. Love is 66 years old, born in 1959.

What stocks does Ted W. Love currently own?

As insider, Dr. Ted W. Love owns shares in one company:

Company Title Shares Price per share Total value
Global Blood Therapeutics, Inc. (GBT) Pres, Chief Executive Officer & Director 1,034,633 $68.49 $70,862,014

What does Global Blood Therapeutics, Inc. do?

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.

GBT logo
GBT
Global Blood Therapeutics, Inc.
$68.49

Ted W. Love insider trading

Global Blood Therapeutics, Inc.

Dr. Ted W. Love has made 7 insider trades between 2015-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 87,500 units of GBT stock on 13 Dec 2019. As of 27 Sep 2022 he still owns at least 1,034,633 units of GBT stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 18,291 $16.4 $299,972
Option
Stock Option (Right to Buy) 18,291 $16.4 $299,972
Option
Restricted Stock Units 9,109 N/A N/A
Option
Restricted Stock Units 9,444 N/A N/A
Option
Common Stock 9,444 N/A N/A
Option
Common Stock 9,109 N/A N/A
Option
Restricted Stock Units 8,955 N/A N/A
Option
Restricted Stock Units 11,250 N/A N/A
Option
Common Stock 20,205 N/A N/A
Option
Restricted Stock Units 9,445 N/A N/A
Option
Common Stock 9,445 N/A N/A
Option
Restricted Stock Units 8,955 N/A N/A
Option
Common Stock 29,955 N/A N/A
Option
Restricted Stock Units 9,750 N/A N/A
Option
Restricted Stock Units 11,250 N/A N/A
Option
Restricted Stock Units 9,444 N/A N/A
Option
Common Stock 9,444 N/A N/A
Option
Common Stock 29,955 N/A N/A
Option
Restricted Stock Units 29,955 N/A N/A
Option
Restricted Stock Units 42,018 N/A N/A
Option
Common Stock 42,018 N/A N/A
Option
Common Stock 42,017 N/A N/A
Option
Restricted Stock Units 42,017 N/A N/A
Option
Restricted Stock Units 20,205 N/A N/A
Sale
Common Stock 40,000 $80 $3,200,160
Sale
Common Stock 2,817 $80.89 $227,870
Sale
Common Stock 4,007 $70.57 $282,790
Option
Restricted Stock Units 33,063 $21.94 $725,402
Option
Common Stock 33,063 N/A N/A
Sale
Common Stock 40,000 $81.77 $3,270,960
Sale
Common Stock 40,000 $82.77 $3,310,960
Option
Restricted Stock Units 87,500 N/A N/A
Option
Common Stock 87,500 N/A N/A
Sale
Common Stock 40,000 $76.6 $3,063,800
Sale
Common Stock 40,000 $74.82 $2,992,800
Option
Restricted Stock Units 33,062 N/A N/A
Option
Common Stock 33,062 N/A N/A
Option
Restricted Stock Units 35,000 N/A N/A
Option
Common Stock 35,000 N/A N/A
Option
Restricted Stock Units 21,813 N/A N/A
Option
Common Stock 21,813 N/A N/A
Option
Restricted Stock Units 21,812 N/A N/A
Option
Common Stock 21,812 N/A N/A
Option
Restricted Stock Units 21,812 N/A N/A
Option
Stock Option (Right to Buy) 12,194 $16.4 $199,982
Option
Common Stock 12,194 $16.4 $199,982
Option
Common Stock 35,000 N/A N/A
Option
Restricted Stock Units 35,000 N/A N/A
Option
Common Stock 12,063 N/A N/A
Option
Restricted Stock Units 12,063 N/A N/A
Option
Restricted Stock Units 35,000 $59.6 $2,086,000
Option
Common Stock 35,000 $59.6 $2,086,000
Option
Restricted Stock Units 35,000 N/A N/A
Option
Common Stock 35,000 N/A N/A
Option
Common Stock 35,000 N/A N/A
Option
Restricted Stock Units 35,000 N/A N/A
Option
Common Stock 12,062 N/A N/A
Option
Restricted Stock Units 12,062 N/A N/A
Purchase
Common Stock 7,500 $20 $150,000

Global Blood Therapeutics key executives

Global Blood Therapeutics, Inc. executives and other stock owners filed with the SEC: